Wednesday, Jun 29, 2022
Outlook.com

Unable To Sell Sputnik Light Stock, Stelis Biopharma Requests PM Modi For Procurement Of Jabs

Unable To Sell Sputnik Light Stock, Stelis Biopharma Requests PM Modi For Procurement Of Jabs

The founder of Stelis Biopharma requested that the government should acquire the available doses, failing which these will get wasted and the company will face a huge financial loss.

14 May 2022
Biocon To Acquire Viatris' Biosimilar Assets For Up To $3.335 Billion

Biocon To Acquire Viatris' Biosimilar Assets For Up To $3.335 Billion

Viatris will receive cash up to $2.335 billion and Compulsorily Convertible Preference Shares (CCPS) in BBL valued at $1 billion. 

28 February 2022

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement